Gut bacteria are an important part of the human gut's microbiota ecosystem, which is populated by 1014 microorganisms, ten times more than human cells. Gut bacteria play a crucial role in human health, giving necessary nutrients, manufacturing vitamin K, assisting with cellulose digestion, and stimulating angiogenesis and enteric nerve activity, among other things. Intestinal infections cause a lot of morbidity and mortality all around the world. Probiotics are increasingly being utilised to treat a variety of medical disorders, including allergic diseases (atopic dermatitis, perhaps allergic rhinitis), bacterial vaginosis, urinary tract infections, and dental caries or respiratory infections prevention. Probiotics are used to treat a wide range of gastrointestinal (GI) conditions. The gastrointestinal system serves as a vital link between the host and the outside world. It is populated by approximately 10 trillion microorganisms of various types weighing 1–2 kilograms.
Title : Overcoming manufacturing challenges in next-generation probiotics: From anaerobic cultivation to clinical-grade formulation
Jason Ryan, Sacco System, Australia
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: State-of-the-art and new insights
Giuseppinella Melita, University of Study Messina, Italy
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Potential for prebiotic food supplement production from by-products of dried persimmon (Diospyros kaki)
Yasin Ozdemir, Ataturk Horticultural Central Research Institute, Turkey